Literature DB >> 14727893

Formulation and in vitro transfection efficiency of poly (D, L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery.

S Gebrekidan1, B H Woo, P P DeLuca.   

Abstract

The stability, in vitro release, and in vitro cell transfection efficiency of plasmid DNA (pDNA) poly (D,L-lactide-co-glycolide) (PLGA) microsphere formulations were investigated. PLGA microspheres containing free and polylysine (PLL)-complexed pDNA were prepared by a water-oil-water solvent extraction/evaporation technique. Encapsulation enhanced the retention of the supercoiled structure of pDNA as determined by gel electrophoresis. PLL complexation of pDNA prior to encapsulation increased both the stability of the supercoiled form and the encapsulation efficiency. Free pDNA was completely degraded after exposure to DNase, while encapsulation protected the pDNA from enzymatic degradation. Rapid initial in vitro release of pDNA was obtained from microspheres containing free pDNA, while the release from microspheres containing PLL-complexed pDNA was sustained for more than 42 days. Bioactivity of encapsulated pDNA determined by in vitro cell transfection using Chinese hamster ovary cells (CHO) showed that the bioactivity of encapsulated pDNA was retained in both formulations but to a greater extent with PLL-complexed pDNA microspheres. These results demonstrated that PLGA microspheres could be used to formulate a controlled-release delivery system for pDNA that can protect the pDNA from DNase degradation without loss of functional activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 14727893      PMCID: PMC2750452          DOI: 10.1208/pt010428

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  17 in total

Review 1.  Analysis of plasmid DNA from a pharmaceutical perspective.

Authors:  C R Middaugh; R K Evans; D L Montgomery; D R Casimiro
Journal:  J Pharm Sci       Date:  1998-02       Impact factor: 3.534

2.  Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.

Authors:  Y Capan; B H Woo; S Gebrekidan; S Ahmed; P P DeLuca
Journal:  J Control Release       Date:  1999-08-05       Impact factor: 9.776

3.  Cationic liposome--plasmid DNA complexes used for gene transfer retain a significant trapped volume.

Authors:  E K Wasan; A Fairchild; M B Bally
Journal:  J Pharm Sci       Date:  1998-01       Impact factor: 3.534

4.  Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle.

Authors:  R J Mumper; J G Duguid; K Anwer; M K Barron; H Nitta; A P Rolland
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

5.  Cationic liposome-mediated intravenous gene delivery.

Authors:  Y Liu; D Liggitt; W Zhong; G Tu; K Gaensler; R Debs
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

Review 6.  Improved cationic lipid formulations for in vivo gene therapy.

Authors:  P L Felgner; Y J Tsai; L Sukhu; C J Wheeler; M Manthorpe; J Marshall; S H Cheng
Journal:  Ann N Y Acad Sci       Date:  1995-11-27       Impact factor: 5.691

7.  Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids.

Authors:  C W Pouton; P Lucas; B J Thomas; A N Uduehi; D A Milroy; S H Moss
Journal:  J Control Release       Date:  1998-04-30       Impact factor: 9.776

8.  Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice.

Authors:  R Niven; R Pearlman; T Wedeking; J Mackeigan; P Noker; L Simpson-Herren; J G Smith
Journal:  J Pharm Sci       Date:  1998-11       Impact factor: 3.534

9.  Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection.

Authors:  Y Xu; F C Szoka
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

Review 10.  Transfer of genes to humans: early lessons and obstacles to success.

Authors:  R G Crystal
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

View more
  6 in total

1.  In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres.

Authors:  Byung Ho Woo; Kyu-Heum Na; Bhas A Dani; Ge Jiang; B C Thanoo; Patrick P DeLuca
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel.

Authors:  Zaki Megeed; Joseph Cappello; Hamidreza Ghandehari
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

3.  Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.

Authors:  M J Schaefer; J Singh
Journal:  AAPS PharmSciTech       Date:  2000-11-13       Impact factor: 3.246

4.  Sustained-release delivery of octreotide from biodegradable polymeric microspheres.

Authors:  Yun-Seok Rhee; MinJi Sohn; Byung H Woo; B C Thanoo; Patrick P DeLuca; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

Review 5.  Innovative strategies for co-delivering antigens and CpG oligonucleotides.

Authors:  Yogita Krishnamachari; Aliasger K Salem
Journal:  Adv Drug Deliv Rev       Date:  2009-01-19       Impact factor: 15.470

6.  A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.

Authors:  Julia M Martínez Gómez; Stefan Fischer; Noèmi Csaba; Thomas M Kündig; Hans P Merkle; Bruno Gander; Pål Johansen
Journal:  Pharm Res       Date:  2007-05-31       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.